The global occlusion devices market size was valued at USD 3.43 billion in 2025 and is projected to grow from USD 3.63 billion in 2026 to USD 5.77 billion by 2034, registering a CAGR of 5.94% during the forecast period from 2026 to 2034. North America dominated the occlusion devices market with a market share of 39.2% in 2025.
Occlusion devices are specialized medical devices designed to block or restrict blood flow within targeted vessels or anatomical structures for therapeutic purposes. They are widely used in interventional radiology, vascular surgery, and neurovascular procedures to manage conditions such as aneurysms, arteriovenous malformations, fistulas, and bleeding. These devices include metallic plugs, coils, detachable balloons, particles, and liquid embolic agents, with the choice depending on vessel size, blood-flow characteristics, and treatment requirements.
Download a Free Sample To learn more about this report,
Growing Preference for Transcatheter Structural Heart Procedures
The global occlusion devices market is witnessing strong growth due to the increasing adoption of minimally invasive transcatheter procedures for treating structural heart diseases such as atrial septal defect (ASD), patent ductus arteriosus (PDA), and left atrial appendage (LAA) closure. Compared with open-heart surgery, transcatheter occlusion procedures reduce hospital stays, lower complication rates, and enable faster patient recovery.
Increasing Innovation in Next-Generation Occlusion Devices
Manufacturers are increasingly focusing on developing next-generation occlusion devices with improved flexibility, repositionability, and delivery precision to enhance procedural success and patient safety. These advanced devices are designed to simplify implantation while reducing procedural complications, making them suitable for complex cardiovascular and peripheral vascular interventions. Regulatory approvals and continuous product improvements are also strengthening market expansion.
Such product advancements continue to strengthen the global occlusion devices market by expanding treatment options for physicians and patients.
Rising Prevalence of Cardiovascular Diseases
Cardiovascular diseases (CVDs) remain the leading cause of death globally, accounting for approximately 17.9 million deaths annually, according to the World Health Organization. This alarming statistic underscores the critical need for effective treatment options, propelling the demand for occlusion devices. These devices play a vital role in managing various cardiovascular conditions, such as atrial fibrillation and peripheral artery disease, by occluding abnormal blood flow and reducing the risk of complications like stroke.
Additionally, the growing preference for minimally invasive procedures further amplifies this demand, as occlusion devices offer less traumatic alternatives to open-heart surgeries. In the United States, the occlusion devices market is projected to reach USD 1.2 billion by 2024, driven by an ageing population and increasing rates of cardiovascular disorders. Moreover, advancements in device technology and favourable reimbursement policies facilitate wider adoption, thereby contributing to market growth.
High Cost of Advanced Occlusion Devices
The high cost associated with advanced occlusion devices presents a significant barrier to market growth, particularly in low- and middle-income countries. These devices often involve complex manufacturing processes and substantial investment in research and development, leading to elevated prices. In regions with limited healthcare budgets, the affordability of such devices becomes a critical issue, restricting their adoption. Additionally, the lack of adequate reimbursement policies in certain areas exacerbates this challenge, making it difficult for healthcare providers and patients to access these advanced treatment options.
For example, the costliness of chronic total occlusion (CTO) procedures and devices renders them inaccessible to certain patient demographics, particularly those lacking adequate health insurance coverage or financial means. Addressing cost-related barriers through policy reforms, cost-effective manufacturing techniques, and increased awareness is essential to enhance market penetration and ensure equitable access to these life-saving devices.
In January 2026, Boston Scientific: The company continued to provide reimbursement resources for its CROSSBOSS and STINGRAY chronic total occlusion systems, which are used in complex coronary CTO procedures requiring specialized crossing and re-entry devices.
Expansion in Emerging Economies
Emerging economies present significant growth opportunities for the occlusion devices market, driven by increasing healthcare infrastructure development and rising healthcare expenditures. Countries in Asia-Pacific, Latin America, and the Middle East are witnessing a surge in the prevalence of chronic diseases, such as cardiovascular and neurovascular disorders, necessitating advanced treatment options. Government initiatives aimed at improving healthcare access and affordability are facilitating market expansion.
Additionally, collaborations between key players and local healthcare providers are enhancing the availability and adoption of these devices. Such strategic initiatives are expected to drive significant growth in the occlusion devices industry within emerging economies.
Complex Regulatory Approval and Clinical Validation Requirements
Obtaining regulatory approval for occlusion devices remains a major challenge for manufacturers operating in the Occlusion Devices Market. Since these devices are used in critical cardiovascular, neurovascular, and peripheral vascular procedures, they must undergo extensive preclinical evaluations, clinical trials, and long-term safety assessments before receiving regulatory clearance. The approval process is often lengthy, costly, and varies across different countries, delaying product commercialization and increasing development expenses. In addition, manufacturers must continuously generate post-market clinical evidence to demonstrate device safety, efficacy, and long-term performance, further adding to compliance costs and time-to-market.
Occlusion Removal Devices Dominated the Occlusion Devices Market with a 7.08% Share in 2025
The occlusion removal devices segment dominated the occlusion devices market, accounting for 7.08% of the global market share in 2025. The segment's growth is driven by the increasing prevalence of ischemic stroke, peripheral artery disease, and other vascular disorders requiring rapid clot removal. Technological advancements in thrombectomy devices, coupled with the growing adoption of minimally invasive procedures and improved clinical outcomes, continue to strengthen demand.
The embolization devices and support devices segments also hold a significant share of the market, supported by their expanding use in treating aneurysms, vascular malformations, tumors, and other complex interventional procedures.
Request Customizationto receive a tailored report.
Neurology Segment is Expected to Register the Highest CAGR of 7.52% During the Forecast Period
The neurology segment is projected to register the fastest CAGR of 7.52% during the forecast period. Growth is driven by the rising incidence of acute ischemic stroke, increasing awareness of early stroke intervention, and expanding adoption of mechanical thrombectomy procedures.
The cardiology, peripheral vascular diseases, urology, oncology, and gynecology segments continue to contribute substantially to the market, driven by the increasing use of occlusion devices in minimally invasive therapeutic and embolization procedures.
Ambulatory Care Centers Dominated the Occlusion Devices Market with a 7.43% Share in 2025
The ambulatory care centers segment dominated the occlusion devices market, accounting for 7.43% of the global market share in 2025. The segment's leadership is attributed to the increasing preference for outpatient minimally invasive procedures, shorter recovery times, and lower treatment costs compared to inpatient settings.
The hospitals, diagnostic centers & surgical centers, research laboratories & academic institutes, and other end users continue to account for a considerable share of the market, supported by rising patient volumes, expanding clinical research activities, and increasing adoption of advanced occlusion technologies.
Speak to an Analystto discuss market opportunities.
North America held the largest share of the Occlusion Devices Market at 39.2% in 2025, with a market value of USD 1.34 billion. The regional market is projected to grow at a CAGR of 6.41% during the forecast period. Growth is supported by advanced healthcare infrastructure, high procedural volumes, established interventional cardiology and radiology centers, and strong adoption of minimally invasive vascular procedures. The region also benefits from continuous product innovation and the presence of leading medical device manufacturers.
The United States is a major contributor to the North American Occlusion Devices Market, supported by advanced interventional healthcare infrastructure, high adoption of minimally invasive procedures, and a large network of specialized cardiovascular and neurovascular centers. Rising prevalence of vascular disorders, stroke, and structural heart conditions is increasing demand for occlusion technologies. Strong reimbursement infrastructure, product innovation, and the presence of major medical device manufacturers are also supporting market expansion.
Canada is expected to witness steady growth in the Occlusion Devices Market, supported by its established healthcare system, expanding access to interventional procedures, and increasing focus on stroke prevention and vascular disease management. Growing healthcare investment and improvements in specialized treatment capacity are creating opportunities for occlusion device adoption. The increasing use of minimally invasive procedures is also supporting demand for advanced vascular intervention technologies.
Unlock Regional Insightsto access country-level data, & regional trends.
Europe accounted for 27.4% of the Occlusion Devices Market in 2025, with a market value of USD 0.94 billion. The regional market is expected to expand at a CAGR of 6.22%. Growth is supported by well-established healthcare systems, an aging population, increasing prevalence of cardiovascular and neurovascular diseases, and growing preference for minimally invasive interventions. Germany and the United Kingdom are important contributors due to their advanced clinical infrastructure and established interventional treatment capabilities.
Germany is an important market within Europe's Occlusion Devices Market, supported by advanced healthcare infrastructure, strong clinical expertise, and increasing use of interventional cardiology and vascular procedures. The aging population and growing burden of cardiovascular and cerebrovascular diseases are increasing demand for minimally invasive treatment options. Established hospitals and specialized medical centers are also supporting the adoption of advanced occlusion and embolization devices.
The United Kingdom is a key European market for Occlusion Devices, supported by its established healthcare infrastructure and increasing use of minimally invasive vascular and neurovascular procedures. Demand is driven by the growing burden of stroke and cardiovascular diseases, along with the need for effective treatment options that can reduce surgical intervention and hospital stays. Strong clinical expertise and access to specialized healthcare services are expected to support market development.
Asia Pacific represented 23.6% of the Occlusion Devices Market in 2025, with a market value of USD 0.81 billion. The region is projected to record the fastest growth at a CAGR of 8.31%. Expansion is supported by improving healthcare infrastructure, rising healthcare expenditure, increasing prevalence of cardiovascular and cerebrovascular diseases, and growing adoption of minimally invasive procedures. China and Japan are major contributors, while expanding hospital capacity and improved access to interventional radiology are creating additional opportunities across the region.
Japan is an important market within the Asia-Pacific Occlusion Devices Market, supported by advanced healthcare infrastructure, an aging population, and increasing demand for minimally invasive cardiovascular and neurovascular procedures. The rising prevalence of age-related vascular conditions is encouraging the use of specialized occlusion technologies. Strong clinical capabilities and investments in advanced medical technologies are expected to support continued market growth.
China is a major contributor to the Asia-Pacific Occlusion Devices Market, supported by its large patient population, expanding hospital infrastructure, and increasing investment in interventional healthcare. Rising cardiovascular and cerebrovascular disease prevalence is creating greater demand for minimally invasive vascular procedures. Expansion of specialized stroke centers and improvements in access to advanced medical technologies are also supporting market development.
Latin America accounted for 5.8% of the Occlusion Devices Market in 2025, with a market value of USD 0.20 billion. The regional market is projected to grow at a CAGR of 6.73%. Growth is supported by improving access to advanced medical technologies, expanding private healthcare facilities, increasing physician expertise, and greater adoption of minimally invasive vascular and cardiac procedures. Brazil represents an important contributor to regional demand due to its large patient population and expanding healthcare infrastructure.
Brazil is a key market in Latin America's Occlusion Devices Market, supported by its large population, developing healthcare infrastructure, and increasing adoption of minimally invasive cardiovascular and vascular procedures. Growing awareness of advanced treatment options and improvements in specialized medical services are supporting demand. Expansion of private healthcare facilities and increasing physician expertise in interventional procedures are also expected to contribute to market growth.
The Middle East and Africa accounted for 4% of the Occlusion Devices Market in 2025, with a market value of USD 0.14 billion. The region is expected to grow at a CAGR of 5.94%. Market expansion is supported by improving healthcare infrastructure, increasing access to advanced medical technologies, and gradual expansion of private healthcare facilities. Growing physician expertise and greater availability of minimally invasive vascular and cardiac procedures are also creating opportunities for occlusion device adoption.
The UAE is an important market within the Middle East and Africa Occlusion Devices Market, supported by advanced healthcare infrastructure, investment in specialized medical facilities, and increasing adoption of minimally invasive cardiovascular and vascular procedures. Government investment in healthcare modernization and the expansion of private hospitals are improving access to advanced interventional technologies. Growing demand for specialized cardiac and vascular care is expected to support market development.
Customize This Report to Match Your Strategic Objectives
Author's Details
Healthcare Lead
Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, competitive dynamics, and market opportunities. Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.
Artificial Lung Market Size, Share, Growth, Analysis, 2034
Bronchoscopes Market Size, Share, Growth, Analysis, Report, 2034
Aesthetic Threads Market Size, Share, Growth, Forecast, 2034
Middle East And Africa Diabetes Devices Market Size and Forecast 2034
Bladder Scanners Market Size, Share, Growth, Forecast, 2034
Japan Dialyzer Market Size, Top Share, Demand And Forecast to 2034
We are featured on:
sales@straitsresearch.com